Profile for Transition Therapeutics Inc. (TTH)

Company

Financials

Insiders

Filings

Analyst

Earnings

Historical

Profile · Share Information · Key Ratios

Symbol:

Profile for Transition Therapeutics Inc. (TTH:CA)

Business Description:
A product-focused biopharmaceutical company developing novel therapeutics for disease indications with large markets.

Address:

101 College Street, Suite 220, Toronto, Ontario, CA M5G 1L7

Telephone:

(416) 260-7770

Website:

www.transitiontherapeutics.com

Facsimile:

(416) 260-2886

Email:

ccockerham@transitiontherapeutics.com

Details

CEO:

Dr.Tony F. Cruz

Employees:

Market Cap:

63.76 m

Issue Type:

Auditor:

PRICEWATERHOUSE COOPERS LLP

Last Audit:

Indices:

Biotechnology

Industry Classifications

Sector:

Healthcare

CIK:

0001399250

Industry:

Drugs

NAICS:

Pharmaceutical Preparation Manufacturing (325412)

QM ID:

Biotechnology(515:CA)

SIC:

Pharmaceutical Preparations (2834)

Copyright © QuoteMedia. Data delayed at least 15 min. unless otherwise indicated. RT Realtime, EOD End Of Day, PD Previous Day. Market Data powered by QuoteMedia, profiles by Morningstar. Terms of Use.

Research Report

Hotstocked.com has a complete research report available for TTH stock. Download TTH report.

Research Report

Get the full report for FREE

Date:	2008-09-01
Price:	Free
Pages:	4
Document Type:	Adobe Acrobat Reader
	Download TTH report

Example preview:

Summary
Research Report
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Key executives
Comments

Newest articles

Run of River Power Inc.

Electrovaya 1Q Results

Methanex MEOH Progresses DME Project in Egypt

Zongshen PEM Power Systems Inc. Announces Third Quarter 2007 Financial Results

You aren't logged in Log in Register

Home > Companies > Transition Therapeutics Inc.

Profile for Transition Therapeutics Inc. (TTH)

More

Newest articles